Advertisement

Gene Therapy for AIDS

  • Richard A. Morgan
  • W. French Anderson
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

With the number of HIV infected individuals world-wide now estimated in the millions and with no curative treatment or protective vaccine available in the immediate future, all efforts should be pursued to develop novel treatment modalities for AIDS. One potential anti-HIV technology which is rapidly moving from the laboratory to the clinic is commonly refereed to as gene therapy. The nature of this technology, the potential methods by which it could be applied to combat HIV infection, as well as issues related to the safety and the practicality of administrating this technology on a large scale will be discussed.

Keywords

Gene Therapy Producer Cell Line Packaging Cell Line Mouse Hematopoietic Stem Cell Primary Culture Endothelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson, W.F. Prospects for human gene therapy. Science 1984; 226: 401–409.PubMedCrossRefGoogle Scholar
  2. 2.
    Rosenberg, S.A., Aebersold, P., Cornetta, K., et al. Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 1990; 323: 570–578.PubMedCrossRefGoogle Scholar
  3. 3.
    Eglitis, M.A., and Anderson, W.F. Retroviral vectors for introduction of genes into mammalian cells. BioTechniques 1988; 6: 608–614.PubMedGoogle Scholar
  4. 4.
    Baltimore, D. Intracellular immunization. Nature 1988; 335: 395–396.PubMedCrossRefGoogle Scholar
  5. 5.
    Green, M., Ishino, M., and Loewenstein, P.M. Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR driven gene expression. Cell 1989; 58: 215–223.PubMedCrossRefGoogle Scholar
  6. 6.
    Malin, M. H., Bohnlein, S., Hauber, J., and Cullen, B.R. Functional dissection of the HIV-1 Rev trans-activator: derivation of a trans-dominant repressor of Rev function. Cell 1989; 58: 205–214.Google Scholar
  7. 7.
    Trono, D., Feinberg, M.B., and Baltimore, D. HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 1989; 59: 113–120.PubMedCrossRefGoogle Scholar
  8. 8.
    Smith, D.H., Byrn, R.A., Marsters, S.A., et al.: Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science 1987; 238: 1704–1707.PubMedCrossRefGoogle Scholar
  9. 9.
    Deen, C.D., McDougal, J.S., Inacker, R., et al.: A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 1988; 331: 82–84.PubMedCrossRefGoogle Scholar
  10. 10.
    Berger, E.A., Fuerst, T.R., and Moss, B. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 2357–2361.PubMedCrossRefGoogle Scholar
  11. 11.
    Spangrude, G.J., Heimfeld, S., and Weissman, I.L. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58–62PubMedCrossRefGoogle Scholar
  12. Culver, K.W., Morgan, R.A., Osborne, W.R.A., Lee, R.T., Lenschow, D., Able, C., Cornetta, K., Anderson, W.F., and Blaese, R.M. In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys. Human gene therapy, in apress.Google Scholar
  13. 13.
    Thompson, J.A., Haudenschild, C.C., Anderson, K.D., DiPietro, J.M., Anderson, W.F., and Maciag, T. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 7928–7932.PubMedCrossRefGoogle Scholar
  14. 14.
    Morgan, R.A., Looney, D., Muenchau, D., Wong-Staal, R., Gallo, R., and Anderson, W.F. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. AIDS Res. and human retroviruses, 1990; 6: 183–191.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Richard A. Morgan
    • 1
  • W. French Anderson
    • 1
  1. 1.Molecular Hematology Branch, National Heart, Lung and Blood InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations